Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Dietrich

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Breast Cancer (Tokyo, Japan)|December 29, 2018
Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimensChristoph J Rageth, Ravit Rubenov, Cristian Bronz, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|March 16, 2010
Histopathology and microcystin distribution in Lymnaea stagnalis (Gastropoda) following toxic cyanobacterial or dissolved microcystin-LR exposureEmilie Lance, Celine Josso, Daniel Dietrich, et al.
BMC Cancer|March 28, 2013
Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivorsArnoud J Templeton, Beat Thürlimann, Michael Baumann, et al.
BMC Cancer|February 13, 2020
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99Serenella Eppenberger-Castori, Dirk Klingbiel, Thomas Ruhstaller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trialFred T Bosman, Pu Yan, Sabine Tejpar, et al.
International Journal of Colorectal Disease|December 8, 2018
The growing discrepancy between resident training in colonic surgery and the rising number of general surgery graduatesSamuel A Käser, Andreas Rickenbacher, Daniela Cabalzar-Wondberg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 21, 2021
A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumoursStefan Morarasu, Luke O'Brien, Cillian Clancy, et al.
Therapeutic Advances in Medical Oncology|January 15, 2019
Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scoresPiera Gargiulo, Daniel Dietrich, Richard Herrmann, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2018
Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trialSabine Tejpar, Pu Yan, Hubert Piessevaux, et al.
The Lancet. Oncology|February 6, 2008
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trialViviane Hess, Bengt Glimelius, Philipp Grawe, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Breast Cancer (Tokyo, Japan)|December 29, 2018
Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimensChristoph J Rageth, Ravit Rubenov, Cristian Bronz, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|March 16, 2010
Histopathology and microcystin distribution in Lymnaea stagnalis (Gastropoda) following toxic cyanobacterial or dissolved microcystin-LR exposureEmilie Lance, Celine Josso, Daniel Dietrich, et al.
BMC Cancer|March 28, 2013
Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivorsArnoud J Templeton, Beat Thürlimann, Michael Baumann, et al.
BMC Cancer|February 13, 2020
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99Serenella Eppenberger-Castori, Dirk Klingbiel, Thomas Ruhstaller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trialFred T Bosman, Pu Yan, Sabine Tejpar, et al.
International Journal of Colorectal Disease|December 8, 2018
The growing discrepancy between resident training in colonic surgery and the rising number of general surgery graduatesSamuel A Käser, Andreas Rickenbacher, Daniela Cabalzar-Wondberg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 21, 2021
A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumoursStefan Morarasu, Luke O'Brien, Cillian Clancy, et al.
Therapeutic Advances in Medical Oncology|January 15, 2019
Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scoresPiera Gargiulo, Daniel Dietrich, Richard Herrmann, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2018
Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trialSabine Tejpar, Pu Yan, Hubert Piessevaux, et al.
The Lancet. Oncology|February 6, 2008
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trialViviane Hess, Bengt Glimelius, Philipp Grawe, et al.
Pageof 7